ABOUT VISCERAL LEISHMANIASIS
Visceral leishmaniasis (VL) is a neglected tropical disease that threatens tens of thousands of people each year, mostly in the world’s poorest communities. Left untreated, it is fatal in over 95% of cases.
At IDDO, we work with the global VL research community to pool and harmonise clinical trial data, creating stronger evidence to improve treatments and support new drug development. Together, we also develop the tools, resources and research agendas that drive better VL research and save lives.
EXPLORE VISCERAL LEISHMANIASIS DATA
STUDY GROUPS
We bring together VL researchers worldwide in collaborative study groups to identify the most important questions for patient benefit. We then build on this with our expertise in curating and standardising data, which enables individual participant data meta-analyses
VISCERAL LEISHMANIASIS TEAM
DATA GOVERNANCE
The IDDO Visceral Leishmaniasis theme is governed through the IDDO Board, an expert Scientific Advisory Committee, the independent IDDO Data Access Committee, and the IDDO senior management and team leaders. Together, they provide strategic oversight, independent scientific guidance, objective decisions on data access, and day-to-day management of the platform.
